CORONA Remedies Limited (BOM:544644)
India · Delayed Price · Currency is INR 1,738.30
-8.30 (-0.48%)
At close: May 7, 2026
CORONA Remedies Market Cap
CORONA Remedies has a market cap or net worth of 104.72 billion as of May 8, 2026.
Market Cap
104.72B
Enterprise Value
104.81B
Revenue
13.44B
Ranking
n/a
PE Ratio
61.12
Stock Price
1,738.30
Market Cap Chart
Since December 15, 2025, CORONA Remedies's market cap has increased from 87.97B to 104.72B, an increase of 19.04%. That is a compound annual growth rate of 56.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 7, 2026 | 106.60B | 25.85% |
| Dec 31, 2025 | 84.70B | -3.72% |
| Dec 15, 2025 | 87.97B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| J. B. Chemicals & Pharmaceuticals | 343.81B |
| AstraZeneca Pharma India | 213.38B |
| Granules India | 184.20B |
| Rubicon Research | 156.74B |
| Jubilant Pharmova | 155.43B |
| Caplin Point Laboratories | 141.85B |
| CORONA Remedies | 104.72B |
| Viyash Scientific | 96.81B |